Search Results - "Maestro De Las Casas, M"

Biomarkers and intermediate-high risk non-muscle invasive bladder cancer: a multivariate analysis of three different cellular pathways with pronostic implications by Garde-García, H., Redondo-González, E., Maestro-de las Casas, M., Fernández-Pérez, C., Moreno-Sierra, J.

“…Purpose To determine the presence of a group of mutations, and establish the prognostic value for recurrence and progression. Materials and methods Prospective…”
Get full text

Cuantificación inmunomagnética de células tumorales circulantes en pacientes con cáncer de próstata: correlación clínica y patológica by Resel Folkersma, L., Olivier Gómez, C., San José Manso, L., Veganzones de Castro, S., Galante Romo, I., Vidaurreta Lázaro, M., Orden, G.V.de la, Arroyo Fernandez, M., Díaz Rubio, E., Silmi Moyano, A., Maestro de las Casas, M. A.

“…Objetivos: Detección y cuantificación de células tumorales prostáticas circulantes (CTC) en sangre periférica de pacientes con cáncer de próstata (CP) y…”
Get full text

Serum and tissue CEA in colorectal cancer: clinical relevance by Moreno Carretero, G, Cerdán Miguel, F J, Maestro de las Casas, M L, Martínez Cortijo, S, Ortega, M D, Pardo Martínez, M, Balibrea Cantero, J L

“…This article is an analysis of the information derived from the determination of tumor-tissue concentration of CEA in patients with colorectal cancer. To…”
Get more information

285 PROGNOSTIC VALUE OF QUANTIFYING CIRCULATING TUMOURAL CELLS (CTC), CIRCULATING ENDOTHELIAL CELLS (CEC) AND VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) IN HORMONE SENSITIVE METASTATIC PROSTATE CANCER by San Jose Manso, L, Olivier Gomez, C, Resel Folkersma, L, Galante Romo, I, Leon Rueda, M.E, Campanario, F, Casado, J, Hernando Arteche, A, Useros, E, Sanz Casla, M.T, Vidaurreta, M, De La Orden, V, Diaz Rubio, E, Maestro De Las Casas, M

Get full text

Immunomagnetic quantification of circulating tumoral cells in patients with prostate cancer: clinical and pathological correlation by Resel Folkersma, L, Olivier Gómez, C, San José Manso, L, Veganzones de Castro, S, Galante Romo, I, Vidaurreta Lázaro, M, de la Orden, G V, Arroyo Fernández, M, Díaz Rubio, E, Silmi Moyano, A, Maestro de Las Casas, M A

“…To detect and enumerate circulating prostatic tumor cells (CTC) in the peripheral blood of patients with prostate cancer (PC) and study the relationship…”
Get full text

Laboratory's function in clinic practice of breast cancer by Sanz Casla, M Teresa, Maestro de las Casas, M Luisa

Get more information

Loss of heterozygosity in the 9p21 region as an inactivation mechanism of the p16 suppressor gene by Maestro de las Casas, M L, Sanz-Casla, M T, del Barco, V, Moreno, J, Zanna, I, Redondo, E, Fernández, C, Izquierdo, L, Resel Estévez, L

“…To determine the loss of heterozygosity (LOH) on 9p21 (locus D9S1747) in patients with renal carcinoma by analysis of microsatellite polymorphisms. 40 patients…”
Get full text

Epidermal growth factor receptor (EGFR) in the prognosis of bladder carcinoma. Experience of 5 years by Moreno Sierra, J, Maestro de las Casas, M L, Redondo González, E, Fernández Pérez, C, del Barco Barriuso, M T, Sanz Casla, V, Blanco Jiménez, E, Silmi Moyano, A, Resel Estévez, L

“…From November 1992 to November 1993, a prospective study was conducted on 20 controls and 61 patients with bladder carcinoma. EGFR expression was determined by…”
Get full text

P185 (Neu) oncoprotein in the prognosis of bladder carcinoma. Experience of 5 years by Moreno Sierra, J, Maestro de las Casas, M L, Redondo González, E, Fernández Pérez, C, del Barco Barriuso, V, Sanz Casla, M T, Blanco Jiménez, E, Silmi Moyano, A, Resel Estévez, L

“…To determine the utility of p185 oncogene in the biological characterization of transitional cell carcinoma and in the prediction of recurrence, and to analyze…”
Get full text

Usefulness of p53 oncoprotein immunohistochemistry in the follow-up of bladder carcinoma: a 5-year study by Moreno Sierra, J, López García Asenjo, J A, Redondo González, E, Fernández Pérez, C, Maestro de las Casas, M L, Blanco Jiménez, E, Silmi Moyano, A, Resel Estévez, L

“…Mutations in the TP53 gene are frequently detected in some types of malignant tumors (bladder, prostate, kidney, lungs, breast, colon and rectum). This study…”
Get more information

Quantification of p53 oncoprotein in bladder carcinoma: 5-year experience by Moreno Sierra, J, Maestro de las Casas, M L, Fernández Pérez, C, Redondo González, E, Sanz Casla, M T, del Barco Barriuso, V, Blanco Jiménez, E, Silmi Moyano, A, Resel Estévez, L

“…Mutations in the p53 gene are frequently detected in some types of malignant tumors (bladder, prostate, kidney, lung, breast, colon and rectum). This study…”
Get more information

The loss of heterozygosity on the short arm of chromosome 3 in renal carcinoma by Maestro de las Casas, M L, del Barco Barriuso, V, Moreno Sierra, J, Izquierdo López, L, Sanz Casla, M T, Zanna, I, Redondo González, E, Chicharro Almarza, J, Fernández Pérez, C, Resel Estévez, L

“…Renal cancer accounts for 2% of tumors. The most common chromosome abnormality found in renal cancer is the loss of heterozygosity (LOH) on the short arm of…”
Get more information

New quantitative method for determining p53 protein in bladder carcinomas by Moreno Sierra, J, Maestro de las Casas, M L, Ortega Heredia, M D, Chicharro Almarza, J, Blanco Jiménez, E, Silmi Moyano, A, Resel Estévez, L

“…To continue a study protocol on the molecular biology of bladder tumors, analyze protein p53 expression using a new quantitative analytical method and the…”
Get more information

Advances regarding tumor markers in bladder cancer by Moreno Sierra, J, Chicharro Almarza, G J, Torronteras Santiago, J M, Ortega Heredia, M D, Maestro de las Casas, M L, Silmi Moyano, A, Resel Estévez, L

“…Currently, there is not known tumoral marker for vesical carcinoma that would allow to distinguish when a surface tumour may become invasive. To analyze the…”
Get more information

The molecular biology of bladder carcinoma by Moreno Sierra, J, Maestro de las Casas, M L, Chicharro Almarza, J, Ortega Heredia, M D, López García-Asenjo, J, Merino Sánchez, C, Blanco Jiménez, E, Silmi Moyano, A, Rsesel Estévez, L

“…The clinical course of transitional cell carcinoma of the bladder can be difficult to predict due to its potential to invade the muscle layer and/or develop to…”
Get more information

Quantitative determination of epidermal growth factor urothelial receptor (EGFR) in superficial and invasive bladder carcinoma by Moreno Sierra, J, Maestro de las Casas, M, Ortega Heredia, M D, Hermida Gutiérrez, J, Resel Estevez, L

“…The epidermic growth factor (EGF) is a polypeptide which stimulates tissue proliferation. The mechanism of action takes place through an specific membrane…”
Get more information

Serum and tissue quantification of tissue polypeptide antigen (TPA) in transitional cell carcinoma of the bladder by Moreno Sierra, J, Maestro de las Casas, M L, Ortega Heredia, M D, Blanco Jimenez, E, Hermida Gutiérrez, J, Resel Estévez, L

“…Tissue polypeptide antigen (TPA) is a marker of proliferative cellular activity. The aim of this paper is to demonstrate the production of this marker in…”
Get more information

Involvement of epidermal growth factor receptor (EGFR) in the etiopathogenesis of prostatic proliferative processes by Moreno Sierra, J, Fernández Lucas, C, Maestro de las Casas, M L, Ortega Heredia, M D, López Asenjo, J, Resel Estévez, Y L

“…The prostatic growth factors require a membrane specific receptor to which they must bind in order to carry out their biological activities correctly. The aim…”
Get more information

Determination of serum SCC antigen in transitional cell carcinoma of the bladder by Moreno Sierra, J, Maestro de las Casas, M, Ortega Heredia, M D, Rodríguez Molina, J, López Asenjo, J, Blanco Jiménez, E, Hermida Gutiérrez, J, Esteban Fuertes, M, Resel Estevez, L

“…The SCC antigen expresses in the squamous epithelium during the process of a neoplastic transformation. This paper's objective is to evaluate the biological…”
Get more information

Usefulness of carcinoembryonic antigen in transitional cell carcinoma of the bladder by Moreno Sierra, J, Ortega, M D, Blanco Jimenez, E, Maestro de las Casas, M L, Delgado Marti, J A, Hermida Gutierrez, J, Salinas Casado, J, Esteban Fuertes, M, Resel Estévez, L

“…Carcinoembryonic antigen (CEA), described by Gold and Freedman, was the first fetal tumor antigen isolated in tumor homogenates. The present study investigated…”
Get more information